12:53:49 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2025-02-21 Bokslutskommuniké 2024
2024-08-23 Kvartalsrapport 2024-Q2
2024-05-27 Ordinarie utdelning BIOWKS 0.00 SEK
2024-05-24 Årsstämma 2024
2024-02-19 Bokslutskommuniké 2023
2023-08-18 Kvartalsrapport 2023-Q2
2023-05-29 Ordinarie utdelning BIOWKS 0.00 SEK
2023-05-26 Årsstämma 2023
2023-02-17 Bokslutskommuniké 2022
2022-08-19 Kvartalsrapport 2022-Q2
2022-05-23 Ordinarie utdelning BIOWKS 0.00 SEK
2022-05-20 Årsstämma 2022
2022-05-06 Ordinarie utdelning BIOWKS 0.00 SEK
2022-02-18 Bokslutskommuniké 2021
2021-11-25 Extra Bolagsstämma 2021
2021-08-20 Kvartalsrapport 2021-Q2
2021-05-24 Ordinarie utdelning BIOWKS 0.00 SEK
2021-05-21 Årsstämma 2021
2021-02-19 Bokslutskommuniké 2020
2020-08-21 Kvartalsrapport 2020-Q2
2020-05-18 Ordinarie utdelning BIOWKS 0.00 SEK
2020-05-15 Årsstämma 2020
2020-02-14 Bokslutskommuniké 2019
2019-10-18 Kvartalsrapport 2019-Q3
2019-08-23 Kvartalsrapport 2019-Q2
2019-05-27 Ordinarie utdelning BIOWKS 0.00 SEK
2019-05-17 Årsstämma 2019
2019-04-29 Kvartalsrapport 2019-Q1
2019-02-22 Bokslutskommuniké 2018
2018-08-19 Kvartalsrapport 2018-Q2
2018-05-21 Ordinarie utdelning BIOWKS 0.00 SEK
2018-05-18 Årsstämma 2018
2018-02-19 Bokslutskommuniké 2017

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriBioteknik
Bio-Works Technologies är verksamt inom bioteknik. Bolaget utvecklar produkter som separerar och renar molekyler vid framställning av läkemedel. Teknologin baseras på kromatografi som har som avsikt att hantera läkemedelssubstansen. Kunderna återfinns inom den europeiska marknaden där produkterna säljs via distributionspartners och till bolag inom läkemedelsindustrin, samt forskningsinstitut och universitet. Bolaget bildades 2006 och har sitt huvudkontor i Uppsala.
2023-09-06 08:00:00

Bio-Works announces today that Arne Hauge has joined the company as Chief Financial Officer. He is joining as a member of Bio-Works executive team and will report directly to CEO, Jonathan Royce.

As CFO at Bio-Works Arne Hauge will be responsible for financial management of the company, including leadership of the company’s planning processes, and he will work together with management team to drive Bio-Works to the next stage of growth. 

Arne Hauge’s latest position was with Felestad Trading AB, as Interim CFO. Arne is a business driven and strategic CFO, with experience from two start-ups - Halebop in Sweden and Yoigo in Spain. During the last two decades at Telia Company AB, he has held various roles, including Investment Manager, CFO, COO, CCO, Strategy & Business Development and M&A.

Arne has a long history of working with international businesses. Prior to Telia Company AB, he worked for the chemical company AGA AB, with Financial and Business Control, within Region Latin America and Region Eastern Europe, including two years working in Caracas, Venezuela. Arne has a combination of skills from the start-up and scale-up world, but also solid experience in the area of change management.

“I see that Bio-Works has an exciting international expansion ahead. Bio-Works has already built a solid platform and product portfolio within the area of chromatography resins. I am proud to be part of the team and excited to drive Bio-Works through the scale-up phase towards profitability. I’m very impressed over all the competent people that we have in the company, and I am happy to be part of the Bio-Works family!” said Arne Hauge, CFO, Bio-Works.

“Arne is a strategic and multi-faceted CFO with an impressive background and leadership profile that he can leverage to lead all aspects of finance at Bio-Works. His deep experience from manufacturing companies and start-ups is an ideal fit for our next chapter at Bio-Works. We look forward to working together to drive Bio-Works through the next growth phase and to profitability,”
said Jonathan Royce, CEO, Bio-Works.
 
Arne started his position as CFO at Bio-Works on August 1, 2023.